Global Neuromodulation Strategic Market Report 2023-2030: Asia-Pacific and other Emerging Regions Display Impressive Growth Potential

News provided by

Sep 27, 2023, 06:15 ET

DUBLIN, Sept. 27, 2023 /PRNewswire/ -- The "Neuromodulation - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

Global Neuromodulation Market to Reach $11.6 Billion by 2030

The global market for Neuromodulation estimated at US$5.9 Billion in the year 2022, is projected to reach a revised size of US$11.6 Billion by 2030, growing at a CAGR of 8.9% over the analysis period 2022-2030.

The global neuromodulation technology market has witnessed positive trends, building upon a favorable historical review from 2014 to 2021. This market covers various therapeutic applications, including spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, vagus nerve stimulation, transcutaneous electrical nerve stimulation, repetitive transcranial magnetic stimulation, and other technologies.

One of the analyzed segments, spinal cord stimulation, is projected to achieve a substantial 15.3% compound annual growth rate (CAGR) and reach annual sales of US$ Thousand by the end of the analysis period. Similarly, segments like deep brain stimulation and sacral nerve stimulation are expected to contribute significantly to market growth with notable CAGR figures.

The global neuromodulation market demonstrates strong potential, with an estimated valuation of US$ Thousand in annual sales for 2022, and it is forecasted to expand significantly by 2030, driven by a robust CAGR during the analysis period from 2022 to 2030.

Spinal Cord Stimulation, one of the report's analyzed segments, is projected to achieve an 8.9% CAGR and reach US$5.1 Billion by the end of the analysis period. Growth in the Deep Brain Stimulation segment is estimated at a 9.2% CAGR for the next 8-year period.

In the U.S., the neuromodulation market is estimated to reach annual sales of US$ Thousand in 2022. China, as the world's second-largest economy, is expected to experience substantial growth, with annual sales projected to reach US$ Thousand by 2030, driven by a notable CAGR during the analysis period from 2022 to 2030.

Other noteworthy geographic markets, including Japan and Canada, are also expected to exhibit significant growth. Within Europe, several countries are projected to contribute to the market's expansion, demonstrating promising CAGR figures.

The neuromodulation market in the U.S. is estimated at US$2.8 Billion in 2022. China, the world's second-largest economy, is forecasted to reach a projected market size of US$898.5 Million by 2030, with a CAGR of 10.6% during the analysis period from 2022 to 2030.

Among other notable geographic markets are Japan and Canada, each forecasted to grow at rates of 8.5% and 9.1%, respectively, over the 2022-2030 period. Within Europe, Germany is forecasted to grow at an approximate CAGR of 8.2%.

We have analyzed 83 select competitors, thereby delivering a holistic overview of the competitive landscape, including

Abbott Laboratories, Inc.
Boston Scientific Corporation
Autonomix Medical
Biegler GmbH

What`s New?

Special discussions on the global economic climate and market sentiment
Coverage on global competitiveness and key competitor percentage market shares
Market presence analysis across multiple geographies - Strong/Active/Niche/Trivial
Online interactive peer-to-peer collaborative bespoke updates
Access to digital archives and trademarked research platform
Complimentary updates for one year
Access to curated YouTube video transcripts of market sentiments shared by CEOs, domain experts and market influencers via interviews, podcasts, press statements and event keynotes

MARKET OVERVIEW

Neuromodulation - Global Key Competitors Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
Neurological Disorders
A Prelude to Neuromodulation
Indications for Neuromodulation Therapy
Impact of Covid-19 and a Looming Global Recession
2020 Marked as a Year of Disruption & Transformation
World Economic Growth Projections (Real GDP, Annual % Change) for 2020 through 2022
Global Neuromodulation Market Buckles under COVID-19 Strain
Effects of COVID-19 on the Nervous System Sheds Focus on Neuromodulation Applications
GLOBAL MARKET OVERVIEW
Neuromodulation Market Set for a Robust Growth
Neuromodulation Market by Segment
Spinal Cord Stimulation (SCS) and Deep Brain Stimulation (DBS) Represents the Largest Segments
Neuromodulation Devices by Technology
Spinal Cord Stimulation Market (2020): Dollar Market Share of Leading Players in Percentage
Neuromodulation Market by Application
Growing Clinical Applications to Drive Demand
US and Europe Dominate the Market
Asia-Pacific and other Emerging Regions Display Impressive Growth Potential
Competition
Select FDA Approved Neuromodulation Devices in Recent Years
Recent Market Activity
Market Restraints and Challenges
WORLD BRANDS

MARKET TRENDS & DRIVERS

High Incidence of Neurological Disorders: A Key Market Driver
Annual Incidence of Adult-Onset Neurologic Disorders in the US
Rising Geriatric Population and Subsequent Growth in Prevalence of Neurological Disorders
Global Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
Growing Incidence of Neurodegenerative Diseases Propels the Market for Deep Brain Stimulation Devices
Global Alzheimer's Prevalence by Age Group
Diagnosed Prevalence Cases of Parkinson's Disease Across Select Countries
Global DBS Market by Leading Player (2020E): Market Share Breakdown of Revenues for Medtronic, Boston Scientific, and Abbott
Select Available Deep Brain Stimulation Devices Available in the Market
Increasing Cases of Epilepsy Drives the Demand for Vagus Nerve Stimulation Devices
Epilepsy Incidence by Type (2019): Percentage Share Breakdown for Idiopathic and Symptomatic Epilepsy
Symptomatic Epilepsy Incidence by Type (2019): Percentage Share Breakdown of Congenital, Degenerative, Infective, Neoplastic, Trauma, and Vascular Epilepsy
Spinal Cord Injuries Propel the Demand for Spinal Cord Stimulation Devices
Recent Developments in Spinal Cord Injury Treatment
TENS (Transcutaneous electrical nerve stimulation devices) Market Witnesses Rapid Growth
Non-Invasiveness of TMS (Transcranial Magnetic Stimulation) Propelling the adoption of TMS devices
Neuromodulation Technologies to Gain Preference Over Opioids
Tibial Neuromodulation to Impact Overactive Bladder Market

FOCUS ON SELECT PLAYERS (Total 83 Featured)

Abbott Laboratories, Inc.
Boston Scientific Corporation
Aleva Neurotherapeutics SA
Bioness Inc.
Beijing Pins Medical Co., Ltd.
Axonics Modulation Technologies, Inc.
Biegler GmbH
Cirtec Medical Corporation
Cala Health
BioControl Medical Ltd.
Atlantic Therapeutics Group Limited
Bio-Medical Research Limited
Capitol Pain Institute
Autonomix Medical
Bioinduction

For more information about this report visit https://www.researchandmarkets.com/r/bq4w3z

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets